Related Experiment Videos

Retroperitoneal fibrosis after long-term daily use of ergotamine

L Damstrup, T T Jensen

International Urology and Nephrology

|January 1, 1986

Abstract:

A case of retroperitoneal fibrosis is presented. Because of migraine the patient had taken ergotamine daily for 15 years. Ergotamine is discussed as an etiological factor. The current surgical treatments are reviewed.

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

High-load strength training improves outcome in patients with plantar fasciitis: A randomized controlled trial with 12-month follow-up.

Scandinavian journal of medicine & science in sports·2014

Profile of differentially expressed genes mediated by the type III epidermal growth factor receptor mutation expressed in a small-cell lung cancer cell line.

British journal of cancer·2001

The type III epidermal growth factor receptor mutation. Biological significance and potential target for anti-cancer therapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2001

Gene delivery by an epidermal growth factor/DNA polyplex to small cell lung cancer cell lines expressing low levels of epidermal growth factor receptor.

Cancer gene therapy·2000

The dynamic expression of the epidermal growth factor receptor and epidermal growth factor ligand family in a differentiating intestinal epithelial cell line.

Growth factors (Chur, Switzerland)·1999

Amphiregulin acts as an autocrine growth factor in two human polarizing colon cancer lines that exhibit domain selective EGF receptor mitogenesis.

British journal of cancer·1999

See all related articles